(Q38294585)

1 September 2017

Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis (English)

1 reference

1 September 2017

1 reference

7

1 reference

1 September 2017

9

Carlo M Croce

1 reference

1 September 2017

Raffaele Baffa

1

1 reference

1 September 2017

Matteo Fassan

2

1 reference

1 September 2017

Cinzia Sevignani

3

1 reference

1 September 2017

Andrea Vecchione

4

1 reference

1 September 2017

Hideshi Ishii

5

1 reference

1 September 2017

Enrico Giarnieri

6

1 reference

1 September 2017

Leonard G Gomella

8

1 reference

1 September 2017

language of work or name

English

0 references

publication date

12 January 2008

1 reference

1 September 2017

1 reference

1 September 2017

29

1 reference

1 September 2017

4

1 reference

1 September 2017

846-848

1 reference

1 September 2017

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN006

The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN006

FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN006

Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN006

FEZ1/LZTS1 is down-regulated in high-grade bladder cancer, and its restoration suppresses tumorigenicity in transitional cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN006

Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN006

Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN006

4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN006

Inactivation of the FHIT gene favors bladder cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN006

The genetics of transitional cell carcinoma: progress and potential clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN006

Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN006

The murine gene p27Kip1 is haplo-insufficient for tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN006

Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN006

Reduced FEZ1/LZTS1 Expression and Outcome Prediction in Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN006

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGN006

1 reference

1 September 2017

1 reference